Roger J. Hajjar Phospholamban Foundation Biography Publications Institution JoVE Articles Roger J. Hajjar has not added a biography. If you are Roger J. Hajjar and would like to personalize this page please email our Author Liaison for assistance. Publications Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration Circulation. Apr, 2020 | Pubmed ID: 32078387 Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy Molecular Therapy : the Journal of the American Society of Gene Therapy. 03, 2020 | Pubmed ID: 31981493 AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis Molecular Therapy : the Journal of the American Society of Gene Therapy. 02, 2020 | Pubmed ID: 31879190 Echocardiographic Left Ventricular Mass Estimation: Two-Dimensional Area-Length Method is Superior to M-Mode Linear Method in Swine Models of Cardiac Diseases Journal of Cardiovascular Translational Research. Dec, 2019 | Pubmed ID: 31828537 Adult Human Cardiac Stem Cell Supplementation Effectively Increases Contractile Function and Maturation in Human Engineered Cardiac Tissues Stem Cell Research & Therapy. Dec, 2019 | Pubmed ID: 31801634 A Novel Secreted-cAMP Pathway Inhibits Pulmonary Hypertension Via a Feed-forward Mechanism Cardiovascular Research. Sep, 2019 | Pubmed ID: 31529026 Targeted Gene Delivery Through the Respiratory System: Rationale for Intratracheal Gene Transfer Journal of Cardiovascular Development and Disease. Feb, 2019 | Pubmed ID: 30781363 PLN Foundation Circulation Research. 12, 2018 | Pubmed ID: 30566043 Highlighting the Field of Cardiovascular Regenerative Medicine Molecular Therapy : the Journal of the American Society of Gene Therapy. Jul, 2018 | Pubmed ID: 29934254 Functional and Transcriptomic Insights into Pathogenesis of R9C Phospholamban Mutation Using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Journal of Molecular and Cellular Cardiology. Jun, 2018 | Pubmed ID: 29752948 Индукция и характеристика легочной гипертензии у мышей с использованием модели Hypoxia/SU5416 Olympia Bikou1, Roger J. Hajjar2, Lahouaria Hadri1, Yassine Sassi1 1Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, 2Phospholamban Foundation JoVE 59252 Médecine Левый пневмонэктомия, в сочетании с Monocrotaline или Sugen как модель легочной гипертензии у крыс Michael G. Katz1, Anthony S. Fargnoli1, Sarah M. Gubara1, Malik Bisserier1, Yassine Sassi1, Charles R. Bridges1, Roger J. Hajjar1, Lahouaria Hadri1 1Cardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai JoVE 59050 Médecine
Индукция и характеристика легочной гипертензии у мышей с использованием модели Hypoxia/SU5416 Olympia Bikou1, Roger J. Hajjar2, Lahouaria Hadri1, Yassine Sassi1 1Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, 2Phospholamban Foundation JoVE 59252 Médecine
Левый пневмонэктомия, в сочетании с Monocrotaline или Sugen как модель легочной гипертензии у крыс Michael G. Katz1, Anthony S. Fargnoli1, Sarah M. Gubara1, Malik Bisserier1, Yassine Sassi1, Charles R. Bridges1, Roger J. Hajjar1, Lahouaria Hadri1 1Cardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai JoVE 59050 Médecine